Clinical Trials Sponsored by Dong-A ST Co., Ltd.

Total 355 results

Seoul National University Hospital
Dong-A ST

Unknown

Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection Syndrome

Anterior Resection Syndrome
Ajou University School of Medicine
Dong-A Pharmaceutical Co., Ltd.

Completed

Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits (NIMBUS)

Ischemic Stroke | Angiogenesis
Hyuk moon Kim
Dong-A Pharmaceutical Co., Ltd.

Unknown

Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy

Neutropenia

Korea, Republic of
Hong Kong Baptist University
Jiangzhong Pharmaceutical Co., Ltd.

Recruiting

The Efficacy and Safety of a Chinese Herbal Medicine for Long COVID Associated Fatigue

Long COVID

China
The Hong Kong Polytechnic University
Menicon Co., Ltd.

Active, not recruiting

Monthly Replacement Orthokeratology for Myopia Control in Young Children (MR2)

Myopic Progression

Hong Kong
The Hong Kong Polytechnic University
Menicon Co., Ltd.

Completed

Peripheral Optics in Myopia and Orthokeratology

Myopia

China
The Hong Kong Polytechnic University
Menicon Co., Ltd.

Completed

Toric Orthokeratology - Slowing Eye Elongation (TO-SEE)

Astigmatism | Myopia

China
Kwang Dong Pharmaceutical co., ltd.

Recruiting

A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)

Hypoactive Sexual Desire Disorder

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Unknown

Clinical Study of Decitabine and Paclitaxel Combination Therapy

Advanced Breast Cancer

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Unknown

Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers (DW6008)

Healthy

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy

Diabetic Nephropathy

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

Pharmacokinetic Profiles of Metformin With DW1029M (PMD)

Healthy

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

the Pharmacokinetic Profiles of Linagliptin With DW1029M (PLID)

Healthy

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

the Pharmacokinetic Profiles of Losartan With DW1029M (PLD)

Healthy

Korea, Republic of
Kwang Dong Pharmaceutical co., ltd.

Completed

A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.

Overactive Bladder

Korea, Republic of
The Hong Kong Polytechnic University
SEED Co. Ltd.

Completed

Effectiveness of Myopia Control by Breath-O Correct Orthokeratology Lenses

Myopia | Orthokeratology

Hong Kong
The Hong Kong Polytechnic University
Menicon Co., Ltd.

Completed

Discontinuation of Orthokeratology on Eyeball Elongation in Myopic Children (DOEE1)

Myopia

China
The Hong Kong Polytechnic University
Menicon Co., Ltd.

Completed

Retardation of Myopia in Orthokeratology (ROMIO)

Myopia

China
Dong Wha Pharmaceutical Co. Ltd.

Not yet recruiting

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component in Healthy Adult Volunteers in Fed Condition.

DW6014

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers in Fed Condition

Healthy Subjects

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Healthy Subjects

Korea, Republic of
Kwang Dong Pharmaceutical co., ltd.

Completed

A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency

Vitamin D Deficiency
Dong Wha Pharmaceutical Co. Ltd.

Completed

Evaluation of Pharmacokinetics Profiles and Bactericidal Activity of Zabofloxacin (Bacteriocide)

Healthy

Korea, Republic of
Kwang Dong Pharmaceutical co., ltd.

Unknown

To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects

Obesity

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component(Empagliflozin and Metformin) in Healthy Adult Volunteers in Fast Condition.

Healthy Subjects

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers

Healthy Subjects

Korea, Republic of
Kwang Dong Pharmaceutical co., ltd.

Completed

A Prospective, Multi-center Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency

Vitamin D Deficiency
Dong Wha Pharmaceutical Co. Ltd.

Completed

The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer

Diabetic Kidney Disease

Korea, Republic of
Kwang Dong Pharmaceutical co., ltd.

Completed

Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

Drug Toxicity

Korea, Republic of
The Hong Kong Polytechnic University
Menicon Co., Ltd.

Active, not recruiting

Monthly Replacement Orthokeratology for Myopia Control in Existing Lens Wearers (MR1)

Myopic Progression

Hong Kong
The Hong Kong Polytechnic University
SEED Co. Ltd.

Completed

The Safety and Effectiveness of Breath-O Lenses

Myopia | Safety Issues

Hong Kong
The Hong Kong Polytechnic University
Menicon Co., Ltd.

Completed

Discontinuation of Lens Wear in New Ortho-k Children (DOEE2) (DOEE2)

Myopia

China
The Hong Kong Polytechnic University
Phoelia Co. Ltd.

Completed

Endermotherapy for Children With Developmental Disabilities

Cerebral Palsy | Developmental Delay

Hong Kong
Zai Lab (Shanghai) Co., Ltd.

Completed

To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies

Solid Malignancies

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Trial of ZL-1201 in Subjects With Advanced Cancer

Advanced Cancer

United States, China
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Gastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract Carcinoma

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC

HER2 Positive Metastatic Breast Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer

Ovarian Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer

Extensive-stage Small Cell Lung Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC

Hepatocellular Carcinoma (HCC)

China
Zai Lab (Shanghai) Co., Ltd.

Completed

The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer

Ovarian Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma

Unresectable, Recurrent or Metastatic Melanoma | Untreated Mucosal or Acral Lentiginous Melanoma

China
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

Breast Cancer Metastatic

Taiwan
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)

Gastrointestinal Stromal Tumors

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study of Niraparib in Patients With Relapsed Ovarian Cancer

Ovarian Cancer

China
Zai Biopharmaceutical (Suzhou) Co., Ltd.

Recruiting

A Study of ZL-1211 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

United States, China
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient

Platinum-sensitive Relapsed Ovarian Cancer

China
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study to Assess the Efficacy and Safety of DCC-2618 and Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumors After Treatment With Imatinib

Gastrointestinal Stromal Tumor(GIST)

China
Zai Lab (Shanghai) Co., Ltd.

Terminated

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Advanced Hepatocellular Carcinoma (HCC)

China
Dong-A University
Novartis Korea Ltd.

Completed

Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine (CAREER)

Alzheimer's Disease

Korea, Republic of

3

Subscribe